Analyst Consensus ?
ConsensusBuy26 ratings
Bullish1765.4%
Neutral934.6%
Bearish00.0%
FN2 Earnings Intelligence
RTX Corporation complete analyst coverage
RTX Corporation (RTX) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$190.99Current
$85Low
$174.47Average
$250High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 22, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Bernstein | Market Perform | Market Perform | Maintain | Aug 3, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 27, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 24, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 24, 2026 |
| Susquehanna | Positive | Positive | Maintain | Jul 24, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 24, 2026 |
| Jefferies | Buy | Hold | Upgrade | Jun 4, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Apr 22, 2026 |
| Citigroup | Buy | Buy | Maintain | Apr 2, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jan 28, 2026 |
| B of A Securities | Buy | Buy | Maintain | Oct 27, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 22, 2025 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 29, 2025 |
| Baird | Outperform | Neutral | Upgrade | Mar 19, 2025 |
| Deutsche Bank | Buy | Hold | Upgrade | Jan 2, 2025 |
| Alembic Global | Overweight | Neutral | Upgrade | Jul 30, 2024 |
| Redburn Atlantic | Neutral | Buy | Downgrade | Nov 15, 2023 |
| DZ Bank | Hold | Buy | Downgrade | Sep 14, 2023 |
| Argus Research | Hold | Buy | Downgrade | Jul 31, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 26, 2023 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Apr 12, 2023 |
| Vertical Research | Buy | Hold | Upgrade | Jul 10, 2020 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jun 2, 2020 |
| CFRA | Buy | Buy | Maintain | May 7, 2020 |
| Drexel Hamilton | Buy | Buy | Maintain | Mar 19, 2012 |
| Sterne Agee | Buy | Buy | Maintain | Mar 11, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $190.99. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Bernstein | Douglas Harned | $232 | $215.22 | +21.5% | Aug 3, 2026 |
| Argus Research | Analyst unavailable | $245 | $211.9 | +28.3% | Jul 30, 2026 |
| Deutsche Bank | Analyst unavailable | $238 | $217.52 | +24.6% | Jul 27, 2026 |
| Jefferies | Analyst unavailable | $250 | $212.79 | +30.9% | Jul 26, 2026 |
| RBC Capital | Analyst unavailable | $250 | $213.55 | +30.9% | Jul 24, 2026 |
| Susquehanna | Charles Minervino | $245 | $213.24 | +28.3% | Jul 24, 2026 |
| Robert W. Baird | Analyst unavailable | $240 | $209.16 | +25.7% | Jul 24, 2026 |
| Morgan Stanley | Kristine Liwag | $240 | $209.16 | +25.7% | Jul 24, 2026 |
| UBS | Gavin Parsons | $215 | $209.16 | +12.6% | Jul 24, 2026 |
| Wells Fargo | Analyst unavailable | $230 | $209.16 | +20.4% | Jul 24, 2026 |
| Jefferies | Sheila Kahyaoglu | $220 | $172.55 | +15.2% | Jun 4, 2026 |
| Deutsche Bank | Scott Deuschle | $240 | $203.77 | +25.7% | Mar 5, 2026 |
| Bernstein | Analyst unavailable | $204 | $201.38 | +6.8% | Jan 29, 2026 |
| Jefferies | Sheila Kahyaoglu | $225 | $199.46 | +17.8% | Jan 28, 2026 |
| RBC Capital | Analyst unavailable | $230 | $200.88 | +20.4% | Jan 28, 2026 |
| Robert W. Baird | Peter Arment | $225 | $201.28 | +17.8% | Jan 28, 2026 |
| UBS | Gavin Parsons | $208 | $201.28 | +8.9% | Jan 28, 2026 |
| Morgan Stanley | Analyst unavailable | $235 | $201.28 | +23.0% | Jan 28, 2026 |
| UBS | Analyst unavailable | $225 | $201.28 | +17.8% | Jan 27, 2026 |
| Vertical Research | Robert Stallard | $227 | $201.28 | +18.9% | Jan 27, 2026 |
| Susquehanna | Charles Minervino | $230 | $198.13 | +20.4% | Jan 15, 2026 |
| Bernstein | Analyst unavailable | $189 | $188.61 | -1.0% | Jan 6, 2026 |
| UBS | Analyst unavailable | $199 | $187.25 | +4.2% | Jan 5, 2026 |
| Jefferies | Analyst unavailable | $190 | $172.35 | -0.5% | Nov 25, 2025 |
| UBS | Gavin Parsons | $202 | $173.04 | +5.8% | Oct 22, 2025 |
| Morgan Stanley | Analyst unavailable | $215 | $173.04 | +12.6% | Oct 22, 2025 |
| Robert W. Baird | Peter Arment | $203 | $178 | +6.3% | Oct 22, 2025 |
| Susquehanna | Analyst unavailable | $205 | $173.04 | +7.3% | Oct 22, 2025 |
| Goldman Sachs | Noah Poponak | $168 | $173.04 | -12.0% | Oct 22, 2025 |
| Deutsche Bank | Analyst unavailable | $195 | $169.27 | +2.1% | Oct 8, 2025 |
| Bernstein | Douglas Harned | $181 | $166.58 | -5.2% | Oct 6, 2025 |
| Bernstein | Douglas Harned | $157 | $152.61 | -17.8% | Sep 10, 2025 |
| Bernstein | Douglas Harned | $154 | $146.87 | -19.4% | Jul 11, 2025 |
| Deutsche Bank | Scott Deuschle | $140 | $116.01 | -26.7% | Jan 2, 2025 |
| RBC Capital | Ken Herbert | $140 | $117.61 | -26.7% | Dec 19, 2024 |
| Deutsche Bank | Scott Deuschle | $131 | $125.43 | -31.4% | Oct 29, 2024 |
| Barclays | David Strauss | $130 | $125.43 | -31.9% | Oct 29, 2024 |
| Jefferies | Sheila Kahyaoglu | $120 | $127.21 | -37.2% | Oct 24, 2024 |
| Morgan Stanley | Kristine Liwag | $130 | $125.53 | -31.9% | Oct 23, 2024 |
| Susquehanna | Christopher Rolland | $150 | $125.53 | -21.5% | Oct 23, 2024 |
| RBC Capital | Ken Herbert | $130 | $125.53 | -31.9% | Oct 23, 2024 |
| UBS | Gavin Parsons | $133 | $125.53 | -30.4% | Oct 23, 2024 |
| Goldman Sachs | Noah Poponak | $113 | $125.53 | -40.8% | Oct 23, 2024 |
| Bank of America Securities | Ronald Epstein | $145 | $125.53 | -24.1% | Oct 23, 2024 |
| Deutsche Bank | Scott Deuschle | $129 | $123.67 | -32.5% | Oct 3, 2024 |
| Bank of America Securities | Ronald Epstein | $140 | $117.49 | -26.7% | Jul 31, 2024 |
| US Capital Advisors | Pete Skibitski | $134 | $116.88 | -29.8% | Jul 30, 2024 |
| RBC Capital | Ken Herbert | $115 | $114.98 | -39.8% | Jul 26, 2024 |
| RBC Capital | Ken Herbert | $102 | $104.99 | -46.6% | Jul 18, 2024 |
| Barclays | David Strauss | $100 | $102.44 | -47.6% | Apr 30, 2024 |
| Wells Fargo | Matthew Akers | $119 | $101.02 | -37.7% | Apr 25, 2024 |
| RBC Capital | Ken Herbert | $96 | $100.71 | -49.7% | Apr 19, 2024 |
| Jefferies | Sheila Kahyaoglu | $105 | $100.78 | -45.0% | Apr 11, 2024 |
| Wells Fargo | Matthew Akers | $120 | $97.53 | -37.2% | Apr 1, 2024 |
| RBC Capital | Ken Herbert | $82 | $75.1 | -57.1% | Sep 12, 2023 |
| Goldman Sachs | Analyst unavailable | $105 | $98.18 | -45.0% | Jan 13, 2023 |
| Credit Suisse | Analyst unavailable | $103 | $99.87 | -46.1% | Jan 12, 2023 |
| J.P. Morgan | Analyst unavailable | $107 | $98.78 | -44.0% | Dec 12, 2022 |
| Citigroup | Analyst unavailable | $104 | $99.63 | -45.5% | Dec 8, 2022 |
| Wells Fargo | Analyst unavailable | $98 | $90.27 | -48.7% | Jul 27, 2022 |
| Argus Research | John Eade | $112 | $94.91 | -41.4% | May 1, 2022 |
| Wells Fargo | Analyst unavailable | $106 | $99.19 | -44.5% | Apr 27, 2022 |
| RBC Capital | Ken Herbert | $125 | $102.11 | -34.6% | Apr 11, 2022 |
| Barclays | David Strauss | $107 | $97.04 | -44.0% | Mar 14, 2022 |
| Wolfe Research | Michael Maugeri | $111 | $94.36 | -41.9% | Feb 17, 2022 |
| Robert W. Baird | Peter Arment | $106 | $88.98 | -44.5% | Jan 26, 2022 |
| Credit Suisse | Robert Spingarn | $101 | $86.7 | -47.1% | Jul 27, 2021 |
| Cowen & Co. | Cai von Rumohr | $105 | $86.7 | -45.0% | Jul 27, 2021 |
| Langenberg & Co. | Brian Langenberg | $100 | $82.2 | -47.6% | May 3, 2021 |
| UBS | Myles Walton | $96 | $81.16 | -49.7% | Apr 28, 2021 |
| Capital One Financial | Jonathan Raviv | $85 | $81.16 | -55.5% | Apr 28, 2021 |
Track every rating change on RTX the moment it posts. Free to start.
Start freeGet the RTX recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.